Antibiotic

Sandramycin is a cyclic depsipeptide antibiotic with a primary mechanism of action as an antitumor agent. It exhibits potent DNA intercalation and binding, functioning effectively as a cytotoxin in antibody-drug conjugates (ADCs). Sandramycin demonstrates significant activity against Gram-positive bacteria and is recognized for its strong antitumor efficacy, making it a valuable reagent for cancer research and the development of targeted therapies.

Dealanylascamycin is a nucleoside antibiotic that functions as a carbonic anhydrase (CA) inhibitor, exhibiting Ki values of 167, 65.2, 234, and 143 nM for human CA isoforms I, II, IV, and IX, respectively. This compound demonstrates broad-spectrum antibacterial activity, notably effective against pathogens such as Xanthomonas citri with a minimum inhibitory concentration (MIC) of 0.4 μg/mL. Additionally, Dealanylascamycin displays significant cytotoxicity, making it a substance of interest for various biological research applications, particularly in the study of antimicrobial effects and CA inhibition.

Luisol A is an anthraquinone antibiotic analog derived from an aromatic tetraol, recognized as a major metabolite of Streptomyces, a marine actinomycete. This compound exhibits significant antibacterial activity, making it a valuable tool in the study of antibiotic mechanisms and resistance. Its application in research aids in the exploration of novel antimicrobial agents and their effects on various bacterial strains.

Agrochelin is an alkaloid antibiotic with cytotoxic properties, derived from the fermentation of marine Agrobacterium species. This compound exhibits significant cytotoxic activity against various tumor cell lines, making it a valuable tool in cancer research. Agrochelin's mechanism of action may provide insights into antibiotic efficacy and the development of novel therapeutic strategies for oncological applications.

Cefempidone is a third-generation cephalosporin antibiotic that targets penicillin-binding proteins, leading to the inhibition of bacterial cell wall synthesis. This mechanism results in effective antibacterial activity against a range of gram-positive and gram-negative bacteria. Cefempidone is primarily utilized in research applications involving the study of bacterial resistance and the development of new therapeutic strategies against bacterial infections.

Cefamandole lithium is a second-generation broad-spectrum cephalosporin antibiotic that exerts its antibacterial activity by inhibiting bacterial cell wall synthesis. This compound is effective against a variety of Gram-positive and Gram-negative bacteria. Upon metabolism, cefamandole lithium releases free N-methylthiotetrazole (NMTT), which may result in low prothrombinemia, highlighting its importance in biochemical and pharmacological research applications.

Resorcinomycin A is an antibiotic primarily targeting mycobacterial species, demonstrating potent anti-mycobacterial activity. This compound exhibits weaker activity against mycoplasma, making it a valuable reagent for research applications focused on mycobacterial infections and mechanisms of action within this class of pathogens.

IB-96212 is an antitumor antibiotic derived from the marine bacterium Micromonospora sp. It primarily targets cancer cells, demonstrating potent activity against the P-388 leukemia cell line. Additionally, IB-96212 exhibits antimicrobial properties against Micrococcus luteus, making it a valuable compound for various research applications in cancer and microbiology studies.

A-83016F is an antibiotic compound with activity derived from an unidentified actinomycete designated A83016. This compound exhibits weak antimicrobial properties and is primarily used for research applications exploring antibiotic efficacy and microbial resistance mechanisms. Further investigation of A-83016F may provide insights into its potential therapeutic applications and bacteriologic interactions.

TS 155-2 is an antibiotic that acts as an analogue of Bafilomycin, functioning primarily through the inhibition of V-ATPase activity. This enzyme is critical for various cellular processes and has been associated with a range of diseases, including osteopetrosis, male infertility, and renal acidosis. TS 155-2 is valuable for research applications focusing on antimicrobial effects and the physiological roles of V-ATPase in disease contexts.

Pivampicillin is a penicillin antibiotic that acts as a prodrug of ampicillin. Upon metabolism, it converts to ampicillin, exerting bactericidal activity against a broad range of Gram-positive and some Gram-negative bacteria. This compound is commonly utilized in research applications focused on studying bacterial infections and antibiotic resistance mechanisms.

Gentamicin C2 is an aminoglycoside antibiotic that targets bacterial protein synthesis by binding to the 30S ribosomal subunit. It exhibits potent activity against a wide range of gram-negative bacteria, making it a valuable tool in microbial research and clinical applications. Gentamicin C2 is commonly utilized in studies investigating antibiotic resistance and the mechanisms of bacterial pathogenesis.

Dedesosaminyl-5-O-mycaminosyl-10,11-dihydromycinamicin IV is a potent antibiotic targeting bacterial protein synthesis. Its mechanism involves inhibiting the activity of the ribosomal machinery, leading to decreased protein production in susceptible bacteria. This compound is primarily utilized in research applications focused on antibiotic resistance and the development of novel antimicrobial therapies.

Phenelfamycin E is an elfamycin-type antibiotic that targets and exhibits activity against Gram-positive anaerobes, including Clostridium difficile. Its potent antibacterial properties make Phenelfamycin E a valuable tool for research applications focused on combating bacterial infections and studying antibiotic resistance mechanisms.

Formycin B is an antibiotic that primarily targets and exhibits antiparasitic activity against Leishmania species. It has been shown to induce cytotoxic effects on leukocytes, leading to a reversible decrease in neutrophil populations. This compound is valuable for research applications related to myeloid leukemia and can aid in the exploration of therapeutic pathways involving immune modulation.

Streptochlorin is an antibiotic compound with demonstrated antitrypanosomal activity, exhibiting an IC50 value of 230 ng/ml against the GUTat 3.1 strain. It is a valuable tool for research applications focused on the treatment of trypanosomiasis and the exploration of antibiotic mechanisms.

Setomimycin is a potent antibiotic that targets the SARS-CoV-2 main protease (Mpro) with an IC50 value of 12.02 µM. In addition to its antibacterial properties, Setomimycin exhibits anti-inflammatory and antioxidant effects. It also demonstrates significant antiproliferative and antitumor activity, making it a valuable reagent for research in infectious diseases and cancer biology.

Spergualin trihydrochloride is a naturally occurring antibiotic derived from the culture filtrates of Bacillus laterosporus BMG162-aF2. It exhibits significant antimicrobial activity, targeting a range of bacterial pathogens. This compound is utilized in research to explore antibiotic mechanisms and develop novel therapeutic strategies against bacterial infections.

Aurein 5.2 is an antimicrobial peptide with potent antibiotic properties. It exhibits broad-spectrum activity against various bacterial strains, making it a valuable tool in studies related to infection control and antibiotic resistance. Its mechanism of action involves disrupting bacterial cell membranes, leading to cell lysis. Aurein 5.2 is applicable in research focused on antimicrobial development and the understanding of peptide-based therapeutics.

TPU-0037A is an antibiotic that acts as a congener of lydicamycin, specifically targeting Gram-positive bacteria. It effectively inhibits the growth of methicillin-resistant Staphylococcus aureus (MRSA), Bacillus subtilis, and Micrococcus luteus, with minimum inhibitory concentrations (MICs) ranging from 1.56 to 12.5 μg/mL. Notably, TPU-0037A shows no efficacy against Gram-negative strains such as Escherichia coli, Proteus mirabilis, Proteus vulgaris, or Pseudomonas aeruginosa, with MICs exceeding 50 μg/mL. This compound is valuable for research applications focused on antibiotic resistance and the mechanisms of bacterial growth inhibition.

Levonadifloxacin arginine hydrate is a broad-spectrum antibiotic targeting staphylococcal infections. It demonstrates significant antibacterial activity against both methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) strains. This compound is particularly effective in reducing bacterial load when phagocytized by THP-1 monocytes, making it a valuable tool for research in infectious diseases and antimicrobial resistance.

Chartreusin is an antibiotic that targets specific Gram-positive bacteria and mycobacteria. It demonstrates effective antimicrobial activity against various strains, including Micrococcus fiyogenes v. aureus phage. Chartreusin is primarily utilized in research applications focused on antibacterial properties and the development of novel therapeutic agents.

FCE-25199 is a penem antibiotic with oral bioavailability that exhibits potent antibacterial activity against a range of Gram-positive and Gram-negative bacteria. Its effectiveness in combating bacterial infections makes it a valuable tool for research in microbiology and infectious disease studies. This compound aids in the exploration of antibiotic resistance mechanisms and the development of new therapeutic strategies.

3-O-Demethylfortimicin A is an aminocyclitol antibiotic that exhibits significant antibacterial activity. It is particularly effective against Gram-negative pathogens as well as Staphylococcus species. This compound can be utilized in research applications focusing on antibiotic resistance and the development of new antimicrobial therapies.

Colistin B sulfate is an antibiotic derived from the soil bacterium Bacillus polymyxa. It primarily targets bacterial membranes, disrupting their integrity and leading to cell death. Colistin B sulfate is commonly used in research to study antibiotic resistance mechanisms and the effectiveness of antimicrobial therapies against Gram-negative bacteria.

Dactimicin sulfate is an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. Derived from the bacterium Dactylosporangium matsuzakiense, it is part of the fortimicin antibiotic family. Dactimicin sulfate is valuable in research related to bacterial infections and can be used to investigate the effects on sensitive bacterial strains. Its unique structure and mechanism make it an important tool for studying antibiotic resistance and therapeutic applications.

Septamycin is a metal-complexing polyether antibiotic derived from the bacterium Streptomyces hygroscopicus NRRL 5678. This compound exhibits significant anticoccidial activity, making it useful in studying protozoan infections. Septamycin serves as a valuable reagent in research related to antibiotic development and the mechanisms of bacterial resistance.

Cinerubin B is a glycosylated anthracycline antibiotic that acts primarily as an anticancer agent. Derived from Streptomyces sp. SPB74, it exhibits significant cytotoxicity against a range of cancer cell lines. Cinerubin B is utilized in research for its potential therapeutic applications and to further understand its mechanism of action in cancer treatment.

Cefalonium hydrate is a first-generation β-lactam cephalosporin antibiotic that primarily targets bacterial cell wall synthesis. It exhibits significant antibacterial activity against Gram-positive bacteria, making it an essential tool for research into bovine mastitis and related infections. This reagent is crucial for studying the efficacy of treatments and understanding the mechanisms of resistance in affected livestock.

Enterocin is an antibiotic that primarily targets gram-positive and certain gram-negative bacteria, exhibiting bacteriostatic activity. Due to its specificity, Enterocin shows no effectiveness against fungi and yeast. It is utilized in research applications focused on bacterial infections and the development of novel antimicrobial agents.

Antibiotic Adjuvant 1 is a chemical compound that functions as an antibiotic adjuvant by enhancing the efficacy of antibiotics. It has demonstrated minimal intrinsic antibacterial activity, with a minimum inhibitory concentration (MIC) greater than 128 µg/mL. Notably, it significantly potentiates the activity of Cloxacillin, achieving a 66-fold increase in effectiveness, indicating a strong synergistic effect. This compound is useful for research applications focused on antibiotic enhancement and the study of synergistic drug interactions.

Lincophenicol is an antibiotic that functions by inhibiting the puromycin reaction catalyzed by Escherichia coli ribosomal peptidyl transferase. This compound also prevents the binding of specific molecules to the Escherichia coli ribosome. Lincophenicol's dual mechanism of action reveals its potential in research applications aimed at understanding antibiotic resistance and ribosomal function.

Alalevonadifloxacin hydrochloride is a potent antibiotic specifically targeting methicillin-resistant Staphylococcus aureus (MRSA). This orally active compound demonstrates significant antibacterial activity, making it a valuable tool in combating resistant bacterial infections. It is primarily utilized in research applications focused on developing novel therapeutic strategies against resistant strains of Staphylococcus aureus.

CcpA-IN-1 is an antibiotic that targets Staphylococcus aureus, inhibiting the function of the catabolite control protein A (CcpA). This compound exhibits significant bactericidal activity, with a minimum inhibitory concentration (MIC) of 460 nM. CcpA-IN-1 is primarily utilized in research applications focused on antibiotic resistance and bacterial pathogenesis.

Asterric Acid is an antibiotic fungal metabolite that selectively inhibits the binding of the vasoconstrictor endothelin-1 (ET-1) to the ETA receptor in A10 cells at a concentration of 0.1 μM. Additionally, derivatives of asterric acid demonstrate the ability to inhibit VEGF-induced tube formation in human umbilical vein endothelial cells at concentrations ranging from 3 to 10 μM, indicating its potential as an antiangiogenic agent for therapeutic applications.

Clindamycin phosphate hydrochloride is a prodrug of the lincosamide antibiotic clindamycin, which exerts its bacteriostatic activity by inhibiting bacterial protein synthesis. Although Clindamycin phosphate itself lacks in vitro antimicrobial properties, it is rapidly metabolized to active clindamycin in vivo via phosphatase ester hydrolysis. This reagent is valuable for research applications involving acne treatment and bacterial vaginosis, facilitating studies on antibiotic efficacy and resistance mechanisms.

Sinafl oxacin free base is a quinolone antibiotic that exerts its antibacterial activity by inhibiting bacterial DNA gyrase and topoisomerase IV. This compound is effective against a range of Gram-positive and Gram-negative bacteria, making it valuable in the study of bacterial infections and resistance mechanisms. Its use in research applications includes the investigation of antimicrobial susceptibility and the development of new antibiotic strategies.

Thrazarine, a potent oncology antibiotic derived from Streptomyces coerulescens MH802-fF5, acts primarily by inhibiting DNA synthesis, thereby impeding tumor cell proliferation. Its unique ability to specifically induce lysis of tumor cells in the presence of non-activated macrophages highlights its potential in cancer therapeutics. Thrazarine is an important tool for cancer research, offering insights into tumor biology and potential treatment pathways.

Enviomycin (Tuberactinomycin N) functions as an antibacterial antibiotic, specifically targeting bacterial protein synthesis. It exhibits significant activity against Mycobacterium tuberculosis, making it a valuable reagent for studies related to chronic cavitary pulmonary tuberculosis. Enviomycin's unique mechanism supports its use in research focused on tuberculosis treatment and resistance mechanisms.

JH-LPH-28 is a sulfonyl piperazine analog that functions as an inhibitor of UDP-2,3-diacylglucosamine pyrophosphate hydrolase (LpxH). This compound exhibits significant antibiotic activity, demonstrated by a minimum inhibitory concentration (MIC) of 0.83 μg/mL. JH-LPH-28 is a valuable tool for research applications focused on bacterial resistance mechanisms and antibiotic development.

Cefazolin sodium pentahydrate is a first-generation cephalosporin antibiotic that targets bacterial cell wall synthesis. This reagent exhibits broad-spectrum antibacterial activity, making it useful for research involving various bacterial infections. Additionally, cefazolin sodium pentahydrate has been shown to possess anti-inflammatory properties and may contribute to the attenuation of post-operative cognitive dysfunction (POCD) in relevant studies.

WF-3161 is a cyclic tetrapeptide antibiotic derived from the fungus Petriella guttulata, exhibiting significant anti-tumor activity. It effectively inhibits the growth of Trichophyton asteroides with a minimum inhibitory concentration (MIC) of 3 μg/mL. WF-3161 is valuable for research applications focusing on P-388 leukemia and related studies of fungal infections.

Tomaymycin is an antitumor antibiotic that exerts its effects primarily by targeting and inhibiting bacterial protein synthesis. This compound demonstrates significant antimicrobial activity against Gram-positive bacteria, making it a valuable tool in cancer research and infectious disease studies. Its unique mechanism of action offers researchers insights into tumor cell interactions and potential therapeutic applications in oncology.

Teicoplanin A2-5 is an antibiotic that primarily targets Gram-positive bacteria, demonstrating efficacy against both aerobic and anaerobic species. It is widely used in research to study bacterial infections and antibiotic resistance mechanisms. Teicoplanin A2-5 can also be employed in the development of novel therapeutic strategies against resistant strains.

Cefuzonam is an antibiotic that targets bacterial cell wall synthesis, demonstrating potent antibacterial activity against gram-positive bacteria, including Staphylococcus, Streptococcus, and Neisseria gonorrhoeae, with a minimum inhibitory concentration (MIC) ranging from 0.63 to 2 μg/mL. In addition to its antimicrobial properties, Cefuzonam serves as a corrosion inhibitor for mild steel by enhancing the hydrophobicity of the metal surface when exposed to acidic environments. This dual functionality makes it valuable for both clinical applications and materials science research.

Berkeleylactone E is a macrolide antibiotic that targets bacterial protein synthesis. Exhibiting potent antibacterial activity, it has been shown to effectively inhibit the growth of various pathogenic bacteria. This compound is utilized in research applications focused on elucidating antibiotic mechanisms and developing new therapeutic strategies against resistant strains.

Sanfetrinem cilexetil is a prodrug of Sanfetrinem that functions as an orally active antibiotic. It exhibits strong activity against a range of bacterial pathogens, including Staphylococcus aureus, Streptococcus pyogenes, and Escherichia coli in models of murine septicemia, as well as against respiratory infections caused by Streptococcus pneumoniae. This compound is valuable for research applications focused on antibiotic efficacy and the study of bacterial infections.

Bostrycin, also known as Rhodosporin, is an antibiotic with a unique red pigment structure that targets and exhibits strong activity against Gram-positive bacteria. Its mechanism involves disrupting bacterial cell wall synthesis, making it a valuable tool for researching bacterial infections and antibiotic resistance. Bostrycin is particularly relevant in studies focusing on the development of novel antibacterial agents.

Tetronasin sodium is a growth-promoting antibiotic primarily targeting Gram-positive bacteria. It exhibits effective antimicrobial activity, making it suitable for studies related to antibiotic resistance and bacterial infection models. This reagent can be administered orally through the animal's food or water supply, aiding in research applications focused on agricultural and veterinary microbiology.

Leucomycin A13 is a macrolide antibiotic that targets bacterial ribosomes, inhibiting protein synthesis. It exhibits significant antibacterial activity against Bacillus subtilis, Staphylococcus aureus, Micrococcus luteus, and Escherichia coli, with minimum inhibitory concentration (MIC) values of 0.16, 0.16, 0.08, and >10 μg/mL, respectively. Its ribosomal binding affinity is characterized by an IC50 value of 1.2 μM, making it a valuable reagent for research into antibiotic mechanisms and resistance.